Renaissance Technologies (RenTech)'s NRC Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 325,384 shares of NRC Health (NRC) worth $7.02 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 53 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in NRC, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2018, adding 95,500 shares. Largest reduction occurred in Q1 2021, reducing 59,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s NRC Health (NRC) Holding Value Over Time
Track share changes against reported price movement
Quarterly NRC Health (NRC) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -15,400 | Reduce 4.52% | 325,384 | $21.57 |
| Q1 2026 | -10,300 | Reduce 2.93% | 340,784 | $16.98 |
| Q4 2025 | -24,000 | Reduce 6.40% | 351,084 | $18.77 |
| Q3 2025 | +3,100 | Add 0.83% | 375,084 | $12.78 |
| Q2 2025 | +1,500 | Add 0.40% | 371,984 | $16.80 |
| Q1 2025 | -34,402 | Reduce 8.50% | 370,484 | $12.80 |
| Q4 2024 | +25,002 | Add 6.58% | 404,886 | $17.64 |
| Q3 2024 | -53,000 | Reduce 12.24% | 379,884 | $22.86 |
| Q2 2024 | +54,600 | Add 14.43% | 432,884 | $22.95 |
| Q1 2024 | +4,700 | Add 1.26% | 378,284 | $39.61 |
| Q4 2023 | +6,200 | Add 1.69% | 373,584 | $39.56 |
| Q3 2023 | -2,200 | Reduce 0.60% | 367,384 | $44.37 |
| Q2 2023 | +2,600 | Add 0.71% | 369,584 | $0.04 |
| Q1 2023 | +1,700 | Add 0.47% | 366,984 | $0.04 |
| Q4 2022 | -27,800 | Reduce 7.07% | 365,284 | $0.04 |
| Q3 2022 | -34,700 | Reduce 8.11% | 393,084 | $39.80 |
| Q2 2022 | -4,200 | Reduce 0.97% | 427,784 | $38.28 |
| Q1 2022 | -12,700 | Reduce 2.86% | 431,984 | $39.65 |
| Q4 2021 | +3,300 | Add 0.75% | 444,684 | $41.52 |
| Q3 2021 | -9,300 | Reduce 2.06% | 441,384 | $42.17 |
| Q2 2021 | -31,900 | Reduce 6.61% | 450,684 | $45.90 |
| Q1 2021 | -59,400 | Reduce 10.96% | 482,584 | $46.83 |
| Q4 2020 | +4,184 | Add 0.78% | 541,984 | $42.75 |
| Q3 2020 | -28,700 | Reduce 5.07% | 537,800 | $49.21 |
| Q2 2020 | -39,400 | Reduce 6.50% | 566,500 | $58.21 |
| Q1 2020 | +35,100 | Add 6.15% | 605,900 | $45.48 |
| Q4 2019 | +24,000 | Add 4.39% | 570,800 | $65.94 |
| Q3 2019 | +33,000 | Add 6.42% | 546,800 | $57.75 |
| Q2 2019 | +21,100 | Add 4.28% | 513,800 | $57.59 |
| Q1 2019 | +20,100 | Add 4.25% | 492,700 | $38.60 |
| Q4 2018 | -8,500 | Reduce 1.77% | 472,600 | $38.14 |
| Q3 2018 | +95,500 | Add 24.77% | 481,100 | $38.60 |
| Q2 2018 | +38,800 | Add 11.19% | 385,600 | $37.40 |
| Q1 2018 | +56,900 | Add 19.63% | 346,800 | $29.25 |
| Q4 2017 | +61,900 | Add 27.15% | 289,900 | $37.30 |
| Q3 2017 | +54,800 | Add 31.64% | 228,000 | $37.70 |
| Q2 2017 | +34,800 | Add 25.14% | 173,200 | $26.90 |
| Q1 2017 | +11,200 | Add 8.81% | 138,400 | $19.70 |
| Q4 2016 | +18,511 | Add 17.03% | 127,200 | $19.00 |
| Q3 2016 | +6,889 | Add 6.77% | 108,689 | $16.29 |
| Q2 2016 | +28,900 | Add 39.64% | 101,800 | $13.70 |
| Q1 2016 | +11,600 | Add 18.92% | 72,900 | $15.56 |
| Q4 2015 | +3,900 | Add 6.79% | 61,300 | $16.04 |
| Q3 2015 | -200 | Reduce 0.35% | 57,400 | $11.93 |
| Q2 2015 | +8,361 | Add 16.98% | 57,600 | $14.20 |
| Q1 2015 | +5,736 | Add 13.19% | 49,239 | $14.40 |
| Q4 2014 | -1,797 | Reduce 3.97% | 43,503 | $14.00 |
| Q3 2014 | -3,500 | Reduce 7.17% | 45,300 | $13.00 |
| Q2 2014 | +3,810 | Add 8.47% | 48,800 | $14.00 |
| Q1 2014 | -15,410 | Reduce 25.51% | 44,990 | $16.58 |
| Q4 2013 | -1,532 | Reduce 2.47% | 60,400 | $18.82 |
| Q3 2013 | -5,868 | Reduce 8.65% | 61,932 | $18.83 |
| Q2 2013 | +67,800 | Add 0.00% | 67,800 | $17.99 |
Renaissance Technologies (RenTech)'s NRC Health Investment FAQs
Renaissance Technologies (RenTech) first purchased NRC Health (NRC) in Q2 2013, acquiring 67,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held NRC Health (NRC) for 53 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to NRC Health (NRC) was in Q3 2018, adding 481,100 shares worth $18.57 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 325,384 shares of NRC Health (NRC), valued at approximately $7.02 M.
As of the Q2 2026 filing, NRC Health (NRC) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in NRC Health (NRC) was 605,900 shares, as reported at the end of Q1 2020.